{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:23:32Z","timestamp":1793046212714,"version":"4.5.0"},"reference-count":41,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.3201\/eid2808.211787","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T10:33:38Z","timestamp":1659782018000},"page":"1559-1568","source":"Crossref","is-referenced-by-count":44,"title":["Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies1"],"prefix":"10.3201","volume":"28","author":[{"given":"Hung-Yuan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex P.","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"McAleenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Savovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Horby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.C.","family":"Sterne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2808.211787-202208060630-R1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings.","volume":"19","author":"Frame","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2808.211787-202208060630-R2","first-page":"1","article-title":"Lassa fever in West African sub-region: an overview.","volume":"44","author":"Ogbu","year":"2007","journal-title":"J Vector Borne Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-642-56029-3_4","article-title":"Lassa fever.","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"key-10.3201\/eid2808.211787-202208060630-R4","unstructured":"World Health Organization. Lassa fever. 2021 [cited 2022 Mar 22]. https:\/\/www.who.int\/health-topics\/lassa-fever"},{"key":"key-10.3201\/eid2808.211787-202208060630-R5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever.","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever.","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","article-title":"Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.","volume":"311","author":"Fisher-Hoch","year":"1995","journal-title":"BMJ"},{"key":"key-10.3201\/eid2808.211787-202208060630-R8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1073\/pnas.86.1.317","article-title":"Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene.","volume":"86","author":"Fisher-Hoch","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2808.211787-202208060630-R9","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","article-title":"Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.","volume":"26","author":"Lukashevich","year":"2008","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2808.211787-202208060630-R10","unstructured":"CEPI Press Office. CEPI partner INOVIO launches Lassa vaccine phase I trial in West Africa. 2021 Feb 23 [cited 2022 Mar 22]. https:\/\/cepi.net\/news_cepi\/cepi-partner-inovio-launches-lassa-vaccine-phase-i-trial-in-west-africa"},{"key":"key-10.3201\/eid2808.211787-202208060630-R11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin.","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2808.211787-202208060630-R12","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict sierra leone.","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1473-3099(18)30121-X","article-title":"Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.","volume":"18","author":"Okokhere","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/trstmh\/tru009","article-title":"Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone.","volume":"108","author":"Dahmane","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid2808.211787-202208060630-R15","doi-asserted-by":"publisher","first-page":"103673","DOI":"10.1016\/j.dib.2019.01.021","article-title":"Data set on Lassa fever in post-conflict Sierra Leone.","volume":"23","author":"Shaffer","year":"2019","journal-title":"Data Brief"},{"key":"key-10.3201\/eid2808.211787-202208060630-R16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.trstmh.2009.07.008","article-title":"Prevention of lassa Fever in Nigeria.","volume":"104","author":"Inegbenebor","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid2808.211787-202208060630-R17","doi-asserted-by":"publisher","first-page":"e1011","DOI":"10.1016\/j.ijid.2013.05.015","article-title":"Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).","volume":"17","author":"Ajayi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R18","doi-asserted-by":"publisher","first-page":"e0009522","DOI":"10.1371\/journal.pntd.0009522","article-title":"Time to reconsider the role of ribavirin in Lassa fever.","volume":"15","author":"Salam","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R19","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"key-10.3201\/eid2808.211787-202208060630-R20","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535.","DOI":"10.1136\/bmj.b2535"},{"key":"key-10.3201\/eid2808.211787-202208060630-R21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews.","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"key-10.3201\/eid2808.211787-202208060630-R22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"key-10.3201\/eid2808.211787-202208060630-R23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijid.2017.11.007","article-title":"The challenges of detecting and responding to a Lassa fever outbreak in an Ebola-affected setting.","volume":"66","author":"Hamblion","year":"2018","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R24","unstructured":"Allan R, Mardell S, Ladbury R, Pearce E, Skinner K, Saluzzo JF,  The progression from endemic to epidemic Lassa fever in war-torn West Africa. In: Saluzzo JF, Dodet B, editors. Emergence and control of rodent-borne viral diseases: hantaviral and arenal diseases: congr\u00e8s, Annecy, 28\u201331 Octobre 1998. 1st edition. Paris: Elsevier; 1999. p. 197\u2013205."},{"key":"key-10.3201\/eid2808.211787-202208060630-R25","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.ijid.2010.02.1953","article-title":"A retrospective laboratory analysis of clinically diagnosed Lassa fever cases in a tertiary hospital in Nigeria.","volume":"1","author":"Ehichioya","year":"2010","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0166-3542(92)90073-E","article-title":"Unexpected adverse reactions during a clinical trial in rural west Africa.","volume":"19","author":"Fisher-Hoch","year":"1992","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2808.211787-202208060630-R27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3810\/pgm.2009.05.2014","article-title":"Original research: Intravenous ribavirin\u2014review of the FDA\u2019s Emergency Investigational New Drug Database (1997-2008) and literature review.","volume":"121","author":"Riner","year":"2009","journal-title":"Postgrad Med"},{"key":"key-10.3201\/eid2808.211787-202208060630-R28","first-page":"S89","article-title":"Mortality among confirmed Lassa fever cases during the 2017\u20132019 outbreak in Ondo State, Nigeria","volume":"113","author":"Ilesanmi","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid2808.211787-202208060630-R29","doi-asserted-by":"publisher","first-page":"e1839","DOI":"10.1371\/journal.pntd.0001839","article-title":"Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.","volume":"6","author":"Asogun","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1684\/mst.2015.0459","article-title":"Les parasitoses intestinales sont encore fr\u00e9quentes.","volume":"25","author":"Bouree","year":"2015","journal-title":"Med Sante Trop"},{"key":"key-10.3201\/eid2808.211787-202208060630-R31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2105\/AJPH.2017.304186","article-title":"Mortality among confirmed Lassa fever cases during the 2015\u20132016 outbreak in Nigeria.","volume":"108","author":"Buba","year":"2018","journal-title":"Am J Public Health"},{"key":"key-10.3201\/eid2808.211787-202208060630-R32","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3201\/eid2506.181035","article-title":"Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1\u2013May 6, 2018.","volume":"25","author":"Ilori","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R33","first-page":"598","article-title":"Clinical profile of Lassa fever patients in Abakaliki, south-eastern Nigeria, January\u2013March 2018.","volume":"9","author":"Joseph","year":"2019","journal-title":"Ann Med Health Sci Res"},{"key":"key-10.3201\/eid2808.211787-202208060630-R34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","article-title":"A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy.","volume":"297","author":"Price","year":"1988","journal-title":"BMJ"},{"key":"key-10.3201\/eid2808.211787-202208060630-R35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4269\/ajtmh.20-0773","article-title":"Lassa fever among children in Eastern Province, Sierra Leone: a 7-year retrospective analysis (2012\u20132018).","volume":"104","author":"Samuels","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2808.211787-202208060630-R36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jinf.2020.01.021","article-title":"High heart rate at admission as a predictive factor of mortality in hospitalized patients with Lassa fever: An observational cohort study in Sierra Leone.","volume":"80","author":"Wauquier","year":"2020","journal-title":"J Infect"},{"key":"key-10.3201\/eid2808.211787-202208060630-R37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.","volume":"51","author":"Bausch","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R38","unstructured":"World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for front-line health workers: inerim emergency guidance for country adaptation. 2016 Feb [cited 2022 Mar 22]. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/205570\/9789241549608_eng.pdf"},{"key":"key-10.3201\/eid2808.211787-202208060630-R39","unstructured":"World Health Organization. WHO R&D blueprint. \u201cEfficacy trials of Lassa therapeutics: endpoints, trial design, site selection\u201d WHO workshop\u2014final report. 2018 Apr 25 [cited 2022 Mar 22]. https:\/\/www.who.int\/blueprint\/what\/norms-standards\/LassaTxeval_FinalmeetingReport.pdf"},{"key":"key-10.3201\/eid2808.211787-202208060630-R40","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/cid\/cix406","article-title":"Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever.","volume":"65","author":"Raabe","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2808.211787-202208060630-R41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijid.2019.07.015","article-title":"Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis.","volume":"87","author":"Eberhardt","year":"2019","journal-title":"Int J Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/8\/21-1787_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:56:23Z","timestamp":1732989383000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/8\/21-1787_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2808.211787","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}